Product Name:1-(4-bromo-2-methoxy-6-methyl-phenyl)-3-(2-trimethylsilylethoxymethyl)hexahydropyrimidine-2,4-dione

IUPAC Name:1-(4-bromo-2-methoxy-6-methylphenyl)-3-{[2-(trimethylsilyl)ethoxy]methyl}-1,3-diazinane-2,4-dione

CAS:2940958-65-4
Molecular Formula:C18H27BrN2O4Si
Purity:95%
Catalog Number:CM1076998
Molecular Weight:443.41

Packing Unit Available Stock Price($) Quantity
CM1076998-100mg in stock ǜưȬ
CM1076998-250mg in stock ƎNJȬ
CM1076998-500mg in stock NJȬț
CM1076998-1g in stock ũũȬƦ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:2940958-65-4
Molecular Formula:C18H27BrN2O4Si
Melting Point:-
Smiles Code:COC1=CC(Br)=CC(C)=C1N1CCC(=O)N(COCC[Si](C)(C)C)C1=O
Density:
Catalog Number:CM1076998
Molecular Weight:443.41
Boiling Point:
MDL No:
Storage:

Category Infos

PROTAC-E3 Ligase Ligands
Bifunctional degrader molecules, also called proteolysis-targeting chimeras (PROTACs), are a new modality of chemical tools and potential therapeutics to understand and treat human disease. A required PROTAC component is a ligand binding to an E3 ubiquitin ligase, which is then joined to another ligand binding to a protein to be degraded via the ubiquitin–proteasome system. The advent of nonpeptidic small-molecule E3 ligase ligands revolutionized the field and ushered in the design of drug-like PROTACs with potent and selective degradation activity.
PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
Proteolysis-Targeting Chimeras | PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
PROTAC (Proteolysis-Targeting Chimeras) is a promising approach in drug discovery that involves the use of small molecules to target specific proteins for degradation by the cellular machinery.